Epilepsy client on Dilantin and Amlodipine

A calcium channel blocker and Dilantin for seizures can create more seizures and cramps. Why would a doctor prescribed these two meds at the same time for an epilepsy patient?

The epilepsy patient has no appetite and experiences more seizures and nausea. A statin medication was also prescribed without CoQ10 dietary supplement.

Only families who are aware of these medications can ask more questions from the doctor and communicate any side effects from the drug combination.

As caregiver, we can only note in our journal that the client has stomach cramps, loss of appetitie, increased nausea and loss of balance.

We care for our clients and so we educate them about the side effects of the medications.

Hopefully, their families can be proactive in their medication management.

Text 408-854-1883 if you need caring caregivers who also is aware and proactive about drug side effects.

card mother

 

Stop taking the medication and seek immediate medical attention if any of the following occur:

  • seizures
  • suicidal thoughts or behaviour
  • symptoms of a serious allergic reaction (such as fever, swollen glands, yellowing of skin or eyes, or flu-like symptoms with skin rash or blistering)
  • symptoms of a serious skin reaction (such as skin rash; red skin; blistering of the lips, eyes, or mouth; skin peeling; fever; or joint pain)

Some people may experience side effects other than those listed.Check with your doctor if you notice any symptom that worries you while you are taking this medication.

Are there any other precautions or warnings for this medication?

Before you begin using a medication, be sure to inform your doctor of any medical conditions or allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should use this medication.

Allergy: Some people who are allergic to carbamazepine or barbiturates also experience allergic reactions to phenytoin. Before you take phenytoin, inform your doctor about any previous adverse reactions you have had to medications, especially other medications for seizures. Contact your doctor at once if you experience signs of an allergic reaction, such as skin rash, itching, difficulty breathing or swelling of the face and throat.

Dental hygiene: Because phenytoin can cause swollen and bleeding gums, it is important to practice good dental hygiene by flossing, brushing, and visiting your dentist regularly. Talk to your doctor to learn more about how to take care of your mouth, gums, and teeth while taking this medication.

Diabetes: Phenytoin can decrease the release of insulin from the pancreas, resulting in higher-than-normal levels of glucose (sugar) in the blood. It may also have an effect on the action of medications used to lower blood sugar for people with diabetes.

If you have diabetes, or are at risk of developing diabetes, discuss with your doctor how this medication may affect your medical condition, how your medical condition may affect the dosing and effectiveness of this medication, and whether any special monitoring is needed. It may be necessary to monitor your blood sugar more closely when starting or stopping phenytoin treatment.

If you experience symptoms of increased blood sugar, such as increased urinary frequency, increased thirst, excessive eating, unexplained weight loss, or a fruity breath odour, contact your doctor.

Drowsiness/reduced alertness: Some people who take phenytoin become drowsy. Avoid activities that require complete mental alertness, judgment, and physical coordination (such as driving a car or performing hazardous tasks) until you establish how you are affected by phenytoin.

Hypersensitivity syndrome: A severe allergic reaction called hypersensitivity syndrome has occurred for some people with the use of phenytoin. Stop taking the medication and get immediate medical attention if you have symptoms of a severe allergic reaction, including fever, swollen glands, yellowing of the skin or eyes, or flu-like symptoms with skin rash or blistering. These reactions may be more frequent in people of Asian origin.

Lactose intolerance: This capsule form of phenytoin contains lactose. If you have galactose intolerance (galactosemia, glucose-galactose malabsorption, or Lapp lactase deficiency), you should not take the capsule form of this medication.

Liver function: Some people have reported liver problems and, in rare instances, liver failure, with the use of phenytoin. These cases have been associated with an allergic reaction that includes fever, skin rashes or hives, or swollen lymph glands. The reaction usually occurs within the first 2 months of treatment.

If you experience symptoms of liver problems such as fatigue, feeling unwell, loss of appetite, nausea, yellowing of the skin or whites of the eyes, dark urine, pale stools, abdominal pain or swelling, and itchy skin, contact your doctor immediately. If you have decreased liver function or liver disease, discuss with your doctor how this medication may affect your medical condition, how your medical condition may affect the dosing and effectiveness of this medication, and whether any special monitoring is needed.

Osteoporosis: Long term use of anti-seizure medications, including phenytoin, may affect the strength of your bones, because these medications reduce the amount of vitamin D available for your body to use. If you have or are at risk for developing osteoporosis, discuss with your doctor the need to take additional vitamin D.

Other medications and alcohol: Many medications and alcoholic beverages interact with phenytoin, causing decreased effectiveness or increased side effects. If you are taking phenytoin, consult with your doctor or pharmacist before taking any other medications or drinking alcoholic beverages.

Regular dosing: Remember that when you are taking phenytoin, it is very important to take the medication exactly as prescribed. Inform your doctor of any condition that prevents you from taking the medication as prescribed (e.g., surgery, illness, difficulty swallowing).

Stopping the medication: Do not stop taking phenytoin without consulting your doctor. Stopping the medication suddenly may cause an increase in the number or severity of seizures. If it is necessary to stop taking this medication, talk to your doctor about how to gradually reduce the dose of the medication before completely stopping.

Suicidal thoughts and behaviour: Some people taking anti-seizure medications may have suicidal thoughts or behaviour. If this happens to you or you notice this in a family member who is taking this medication, contact your doctor immediately. You should be closely monitored by your doctor for emotional and behaviour changes while taking this medication.

Pregnancy: When phenytoin is taken during pregnancy, it may cause harm to the developing baby. This medication should not be used during pregnancy unless the benefits outweigh the risks. If you become pregnant while taking this medication, contact your doctor immediately.

Breast-feeding: This medication passes into breast milk. If you are a breast-feeding mother and are taking phenytoin, it may affect your baby. Talk to your doctor about whether you should continue breast-feeding.

What other drugs could interact with this medication?

There may be an interaction between phenytoin and any of the following:

  • abiraterone
  • acetaminophen
  • acetazolamide
  • alcohol
  • aliskiren
  • allopurinol
  • alpha blockers (e.g., alfuzosin, doxazosin, tamsulosin)
  • amiodarone
  • amphetamines (e.g., dextroamphetamine, lisdexamphetamine)
  • angiotensin receptor blockers (ARBs; e.g., candesartan, irbesartan, losartan)
  • antacids (e.g., aluminum hydroxide, calcium carbonate, magnesium hydroxide)
  • antineoplastic agents (chemotherapy; e.g., carboplatin, cyclophosphamide, etoposide, irinotecan, vincristine)
  • antihistamines (e.g., cetirizine, doxylamine, diphenhydramine, hydroxyzine, loratadine)
  • anti-psychotics (e.g., chlorpromazine, clozapine, haloperidol, olanzapine, quetiapine, risperidone)
  • apixaban
  • aprepitant
  • azelastine
  • azole antifungals (e.g., fluconazole, ketoconazole, voriconazole)
  • barbiturates (e.g., butalbital, phenobarbital)
  • benzodiazepines (e.g., clonazepam, diazepam, lorazepam)
  • birth control pills
  • bisoprolol
  • bosentan
  • brimonidine
  • buprenorphine
  • bupropion
  • buspirone
  • calcitriol
  • calcium channel blockers (e.g., amlodipine, diltiazem, nifedipine, verapamil)

CAN FOCUSED SOUND WAVES FIX RARE ‘GIGGLING’ FORM OF EPILEPSY?

Sensory signals of Epilepsy and natural therapies

Epilepsy

Natural and Complementary Therapies

Many natural compounds also affect the brain and may be able to influence epilepsy; natural compounds will likely be most beneficial as adjuvants to conventional therapies.

Vitamins and Minerals

Epilepsy patients should also be aware that long-term use of anti-epileptic drugs (AEDs) can negatively affect their vitamin and mineral status. For instance, patients taking anti-epileptic drugs (AEDs) have significantly lower levels of vitamin D in their blood (Menon and Harinarayan 2010, Shellhaas and Joshi 2010, Pack 2004, Valsamis et al. 2006, Mintzer S et al 2006). This is because many AEDs increase the activity of a liver enzyme known as cytochrome P450, which also breaks down vitamin D. Vitamin D is essential for the absorption of calcium; consequently, patients taking AEDS absorb less calcium in their diet, which increases their risk of developing osteoporosis. Patients who are taking AEDs may need to take vitamin D and calcium supplements (Fong et al. 2011).

Anti-epileptic drugs have also been shown to reduce levels of several B vitamins, including folate and vitamins B6 and B12 (Sener et al. 2006Linnebank et al. 2011) These vitamins are critical for controlling metabolism in the body; low levels of these vitamins can also lead to low red blood cell levels, causing fatigue and pallor. One of the most serious consequences of the low folate levels caused by AEDs is high levels of the compound homocysteine, a risk factor for heart disease (Sener et al. 2006; Kurul et al 2007, Apeland et al 2001). Elevated levels of homocysteine have been implicated in the increased risk of heart disease seen in epileptics. Moreover, some studies have indicated that elevated homocysteine may contribute to AED resistance or increase seizures in epileptics (Diaz-Arrastia 2000). Based on these findings, some researchers call for routine supplementation with the B vitamins, especially the metabolically active form of folic acid, L-methylfolate, to reduce homocysteine levels (Morrell MJ 2002). Folate deficiencies can also lead to seizures, particularly in infants. Impaired folate transport in the body can be a cause of seizures that do not respond well to typical treatments (Djukic A 2007). In addition, epileptics often have reduced folic acid levels, possibly due to the use of AEDs (Asadi-Pooya 2005). Doctors of epileptics should routinely monitor folic acid, vitamin B12 and homocysteine levels in patients to help prevent an increased risk of cardiovascular disease that could otherwise be treated.

Some forms of epilepsy are directly linked to vitamin B6 deficiencies; these convulsions, known as pyridoxine-dependent seizures, can only be treated with high doses of vitamin B6 (Asadi-Pooya 2008). Low vitamin B6 levels are also associated with general epilepsy. Even in patients without pyridoxine-dependent seizures, low levels of pyridoxine might increase seizure sensitivity, although more research needs to be done to determine if pyridoxine can treat seizures (Gaby 2007). Some types of seizures cannot be treated with pyridoxine, but they can be effectively managed with pyridoxal-5-phosphate, the biologically active form of vitamin B6 (Tamura et al. 2000, Jiao et al. 1997, Wang et al. 2005).

Antioxidants, such as vitamin Evitamin C and selenium are able to mitigate mitochondrial oxidative stress in the brain and other tissues, lowering seizure frequency in various types of epilepsy (Tamai et al. 1988, Zaidi et al. 2004, Savaskan et al. 2003, Yamamoto et al. 2002, Ogunmekan et al. 1979, 1989 and 1985). Animal models have shown that alpha-tocopherol alone is able to prevent several types of seizures (Levy et al 1990; Levy et al 1992). Epileptics are also more likely to have low vitamin E levels, though this may be a result of taking anti-epileptic drugs (Higashi et al. 1980).

Magnesium helps maintain connections between neurons. It has been shown to suppress EEG activity and limit seizure severity in animal models, and magnesium deficiency is associated with seizures in humans (Oladipo 2007; Nuytten et al 1991, Borges et al. 1978). Within the body, ionic magnesium acts as a natural calcium channel blocker, offsetting the excitatory influence of ionic calcium in a manner similar to the calcium channel blocker class of conventional AEDs (Touyz 1991). Moreover, magnesium levels decline sharply following seizures in patients with idiopathic epilepsy (Gupta 1994). In fact, intravenous or intramuscular magnesium is often administered to women to safely prevent eclampsia, a pregnancy-associated disorder characterized by seizures (Bhattacharjee 2011).

A recently developed form of magnesium, known as magnesium-L-threonate, may be particularly effective in epilepsy and other neurological disorders. This form of magnesium appears to be better at penetrating the blood-brain barrier and thus is more efficiently delivered to brain cells (Slutsky et al. 2010, Abumaria et al. 2011). In fact, in an animal model, magnesium-L-threonate boosted magnesium levels in spinal fluid by an impressive 15% compared to virtually no increase with conventional magnesium. Moreover, oral magnesium-L-threonate was able to modulate learning and memory, indicating that it does indeed impact the central nervous system (Abumaria 2011).

Thiamine, manganese and biotin are often low in epileptics as well (Gaby 2007).

Melatonin plays an important role in the brain, particularly in regulating the brain’s sleep-wake cycle. It also exerts a calming effect at the neuronal level by reducing glutaminergic (excitatory) signaling and augmenting GABAergic (inhibitory) signaling (Banach et al. 2011). Melatonin is widely used as a sleep aid and to treat jet lag; the side effects of taking melatonin are mild and it is one of the most commonly used supplements in the United States. Animal models have shown that melatonin can be effective in reducing epileptic seizures (Lima et al. 2011, Costa-Latufo et al. 2002). Melatonin has also been beneficial in humans with epilepsy and is particularly effective in the treatment of cases of juvenile epilepsy that do not respond well to anti-epileptic drugs (AED’s) (Banach et al. 2011). Due to its widespread use and minimal side effects, melatonin has potential to improve control of epilepsy (Fauteck et al. 1999).

Polyunsaturated Fatty Acids (PUFAs), such as omega-3 fatty acids, are a type of essential fat that play an important role in maintaining central nervous system health. Animal studies have suggested that PUFAs, including omega-3 and some omega-6 fatty acids, may be able to modulate neuronal excitability (Blondeau et al. 2002, Taha et al. 2010). This is further supported by the fact that children on the ketogenic diet often have higher levels of PUFAs in their cerebrospinal fluid, which suggests that increased PUFA levels is one of the ways that the ketogenic diet prevents seizures (Xu et al. 2008, Auvin 2011). Clinical trials in adults have yielded mixed results. In one such study, 57 epileptic patients were given 1 g EPA and 0.7 g DHA daily. Seizure activity was reduced over the first six weeks, although the effect was temporary. The researchers called for more in-depth studies, with larger doses and larger observational groups (Yuen AW et al 2005). However, a randomized controlled trial did not find that fish oil reduced seizure frequency; although, the study did find, that PUFAs reduced seizures when administered in an open-label format, meaning when subjects knew that they were not receiving a placebo (Bromfeld et al. 2008). An ongoing National Institutes of Health-sponsored trial is examining the effects of fish oil on cardiac health in epileptics (ClinicalTrials.gov).

Life Extension suggests that the omega-6 to omega-3 ratio should be kept below 4 to 1 for optimal health. More information on testing and optimizing your omega-6 to omega-3 ratio can be found in the Life Extension Magazine article entitled “Optimize Your Omega-3 Status“.

Resveratrol, derived from red grapes and Japanese knotweed (Polygonum cuspidatum), and the plant Bacopa monnieri both appear to be promising in the management of seizure-related neurotoxicity. Resveratrol and bacopa-derived compounds have been extensively studied in experimental settings and consistently shown to guard against neuronal damage (Jyoti 2007; Hosamani 2009; Kanthasamy 2011; Chung 2011). In the context of epilepsy, numerous mechanisms by which resveratrol might prevent seizures have been proposed (Shetty 2011), and, indeed, in an animal model resveratrol prevented chemical-induced seizures (Wu 2009); though studies on epileptic humans have yet to be performed. Likewise, bacopa has been the subject of several animal model experiments, many of which have revealed a clear benefit relating to seizure frequency and post-seizure brain cell damage (Pandey 2010; Mathew 2010; Krishnakumar 2009). Nonetheless, bacopa also has yet to be studied in a controlled manner in a population of epileptic humans.

Phytocannabinoids (pCBs), which are compounds found in marijuana that closely resemble chemicals the body produces naturally called endocannabinoids, have shown great potential in the treatment of epilepsy. Phytocannabinoids can affect both the central and peripheral nervous system because neurons have receptors that respond directly to binding by cannabinoids. One of the major effects of pCBs is to reduce neuronal excitability by modulating electrical activity around synapses; as a result, these chemicals are sometimes referred to as potential “circuit breakers” for neurological disorders, including epilepsy (Wallace et al. 2003, Katona and Freund 2008). Therefore, researchers have been studying the effects of tetrahydrocannabinol (THC) and other phytocannabinoids on the brain to try to develop new mechanisms for treating epilepsy (Hoffman and Frazier 2011, Hill et al 2012). One small clinical trial found that the phytocannabinoid, cannabidiol, did reduce seizures in epileptics who were already taking AEDs (Cunha et al 1980). Another study that was largely based on epidemiology found an association between marijuana use and decreased risk of seizure (Ng et al 1990). Moreover, it has been reported that patients treated for epilepsy subjectively feel that marijuana use helps eases their epilepsy (Gross et al 2004). More research is needed to determine the efficacy and safety of natural and synthetic cannabinoids for the treatment of seizures. A comprehensive review of studies examining the effects of cannabinoids on seizure frequency in humans is currently being carried out by the Cochrane Epilepsy Group (Gloss and Vickrey 2011). Marijuana is illegal except as a prescribed treatment for medical problems in certain states; Life Extension does not recommend consuming illegal drugs as a treatment for epilepsy. However, the benefits of these phytocannabinoids do suggest that marijuana-derived compounds may soon become an accepted form of therapy for epilepsy and other neurological disorders.

Lifestyle Modifications

Seizure Interruptions. Although auras do not occur in all individuals with seizure disorders, some people are aware of a change in their sensory perception (whether auditory, olfactory, sensory, visual, or gustatory, sometimes involving malaise, vertigo, or the sense of deja vu) that signals the onset of a seizure. Anecdotal reports indicate that some people have learned to interrupt their seizure process by replacing the aura-induced perception with another. In these individuals, the aura is a known signal of seizure onset. For example, if the aura is a smell or unpleasant odor, these individuals can often interrupt the seizure by immediately smelling something else (in general, something with a more pleasing smell than the aura).

Some people are able to take the interruption technique a step further. By simply relying on mental imagery (e.g., remembering a pleasant, positive smell), they can arrest a seizure. Some find that anger can effectively interrupt a seizure; they are able to arrest their seizures by yelling at them. Other individuals who have seizures with an observable onset pattern enlist a support person to shout at them or give them a quick shake when the pattern commences. The techniques that successfully “interrupt” an aura vary from patient to patient and must be performed at a specific time to stop the seizure (Wolf 1994). However, the use of aura interruption may be able to help reduce or eliminate seizures (Elsas et al. 2011).

Stress Reduction Getting a good night’s sleep on a regular basis is a very important component of seizure prevention. Some scientists hypothesize that one major function of REM sleep is to reduce the brain’s susceptibility to epileptogenic influences (Jaseja H 2004). Stress reduction and relaxation techniques such as meditation may also aid in reducing seizures (Swinehart 2008).

Physical exercise can also be an important way to relieve stress that may be particularly beneficial for epileptics. Not only can exercise reduce stress, improve social integration and improve quality of life, regular physical exercise may directly help reduce seizure frequency (Arida et al. 2010). Physical exercise may “desensitize” neurons to emotional stress, helping avert seizures brought on by other triggers (Arida et al. 2009).

Biofeedback, another relaxation technique, can also be helpful. When the autonomic nervous system (or the involuntary nervous system) is in a state of overarousal, the likelihood of seizure activity can increase. Biofeedback is a technique that uses displays of some form of biological monitoring, such as an EEG, to help patients identify how their body responds to certain situations. By observing changes in EEG readings, patients are able to learn how to partially control the electrical activity in their brains and can develop the ability to reduce their risk of having seizures. Although most clinical trials involving biofeedback have been small (Tozzo CA et al 1988; Andrews DJ et al 1992; Ramaratnam S et al 2001), a comprehensive review of many studies found that biofeedback can provide significant relief for epileptics, particularly those that have not had success with anti-epileptic drugs (AEDs) (Tan et al. 2009). On average, almost 75 percent of people who try EEG biofeedback for epilepsy will experience fewer seizures. Biofeedback using other biologic responses, such as slow cortical potential feedback and galvanic skin response has also been promising (Nagai 2011).

Other behavioral interventions may reduce seizure frequency as well. Yoga can improve quality of life and result in fewer seizures (Lundgren et al. 2008, Khan et al. 2010) Acupuncture may also be helpful in seizure prevention. A thorough review of published trials found that acupuncture may be beneficial, but that more and better designed studies need to be done (Cheuk 2008). Studies of the benefits of other relaxation techniques and cognitive behavioral therapy have also found a possible benefit (Ramaratnam 2004).

https://www.lifeextension.com/Protocols/Neurological/Epilepsy/Page-02

Vitamin D rich foods to prevent seizures

Foods that provide vitamin D include:
  • Fatty fish, like tunamackerel, and salmon
  • Foods fortified with vitamin D, like some dairy productsorange juicesoy milk, and cereals
  • Beef liver
  • Cheese
  • Egg yolks

Our client has epilepsy and goes on seizure many times a month. She has poor appetite but loves walking especially during sunny days. She loves cheese. She is on many medications.

card mother

Some anti-seizure medications interfere with how vitamin D is processed in the body. Supplemental vitamin D may be necessary for people who have these risk factors to maintain normal blood levels. A study published in 2012 showed that correcting vitamin D deficiency reduced seizures in people with epilepsy.

Ad

  1. Electrolyte Causes Seizures | Common Symptoms & Treatments‎

     

    Feel Better & Stay Healthy. Your Health Search Engine for Finding Top Medical Information. Search Health & Get Answers – Symptoms, Causes, Conditions, Diagnosis & Treatments.

Epilepsy

Natural and Complementary Therapies

Many natural compounds also affect the brain and may be able to influence epilepsy; natural compounds will likely be most beneficial as adjuvants to conventional therapies.

Vitamins and Minerals

Epilepsy patients should also be aware that long-term use of anti-epileptic drugs (AEDs) can negatively affect their vitamin and mineral status. For instance, patients taking anti-epileptic drugs (AEDs) have significantly lower levels of vitamin D in their blood (Menon and Harinarayan 2010, Shellhaas and Joshi 2010, Pack 2004, Valsamis et al. 2006, Mintzer S et al 2006). This is because many AEDs increase the activity of a liver enzyme known as cytochrome P450, which also breaks down vitamin D. Vitamin D is essential for the absorption of calcium; consequently, patients taking AEDS absorb less calcium in their diet, which increases their risk of developing osteoporosis. Patients who are taking AEDs may need to take vitamin D and calcium supplements (Fong et al. 2011).

Anti-epileptic drugs have also been shown to reduce levels of several B vitamins, including folate and vitamins B6 and B12 (Sener et al. 2006Linnebank et al. 2011) These vitamins are critical for controlling metabolism in the body; low levels of these vitamins can also lead to low red blood cell levels, causing fatigue and pallor. One of the most serious consequences of the low folate levels caused by AEDs is high levels of the compound homocysteine, a risk factor for heart disease (Sener et al. 2006; Kurul et al 2007, Apeland et al 2001). Elevated levels of homocysteine have been implicated in the increased risk of heart disease seen in epileptics. Moreover, some studies have indicated that elevated homocysteine may contribute to AED resistance or increase seizures in epileptics (Diaz-Arrastia 2000). Based on these findings, some researchers call for routine supplementation with the B vitamins, especially the metabolically active form of folic acid, L-methylfolate, to reduce homocysteine levels (Morrell MJ 2002). Folate deficiencies can also lead to seizures, particularly in infants. Impaired folate transport in the body can be a cause of seizures that do not respond well to typical treatments (Djukic A 2007). In addition, epileptics often have reduced folic acid levels, possibly due to the use of AEDs (Asadi-Pooya 2005). Doctors of epileptics should routinely monitor folic acid, vitamin B12 and homocysteine levels in patients to help prevent an increased risk of cardiovascular disease that could otherwise be treated.

Some forms of epilepsy are directly linked to vitamin B6 deficiencies; these convulsions, known as pyridoxine-dependent seizures, can only be treated with high doses of vitamin B6 (Asadi-Pooya 2008). Low vitamin B6 levels are also associated with general epilepsy. Even in patients without pyridoxine-dependent seizures, low levels of pyridoxine might increase seizure sensitivity, although more research needs to be done to determine if pyridoxine can treat seizures (Gaby 2007). Some types of seizures cannot be treated with pyridoxine, but they can be effectively managed with pyridoxal-5-phosphate, the biologically active form of vitamin B6 (Tamura et al. 2000, Jiao et al. 1997, Wang et al. 2005).

Antioxidants, such as vitamin Evitamin C and selenium are able to mitigate mitochondrial oxidative stress in the brain and other tissues, lowering seizure frequency in various types of epilepsy (Tamai et al. 1988, Zaidi et al. 2004, Savaskan et al. 2003, Yamamoto et al. 2002, Ogunmekan et al. 1979, 1989 and 1985). Animal models have shown that alpha-tocopherol alone is able to prevent several types of seizures (Levy et al 1990; Levy et al 1992). Epileptics are also more likely to have low vitamin E levels, though this may be a result of taking anti-epileptic drugs (Higashi et al. 1980).

Magnesium helps maintain connections between neurons. It has been shown to suppress EEG activity and limit seizure severity in animal models, and magnesium deficiency is associated with seizures in humans (Oladipo 2007; Nuytten et al 1991, Borges et al. 1978). Within the body, ionic magnesium acts as a natural calcium channel blocker, offsetting the excitatory influence of ionic calcium in a manner similar to the calcium channel blocker class of conventional AEDs (Touyz 1991). Moreover, magnesium levels decline sharply following seizures in patients with idiopathic epilepsy (Gupta 1994). In fact, intravenous or intramuscular magnesium is often administered to women to safely prevent eclampsia, a pregnancy-associated disorder characterized by seizures (Bhattacharjee 2011).

A recently developed form of magnesium, known as magnesium-L-threonate, may be particularly effective in epilepsy and other neurological disorders. This form of magnesium appears to be better at penetrating the blood-brain barrier and thus is more efficiently delivered to brain cells (Slutsky et al. 2010, Abumaria et al. 2011). In fact, in an animal model, magnesium-L-threonate boosted magnesium levels in spinal fluid by an impressive 15% compared to virtually no increase with conventional magnesium. Moreover, oral magnesium-L-threonate was able to modulate learning and memory, indicating that it does indeed impact the central nervous system (Abumaria 2011).

Thiamine, manganese and biotin are often low in epileptics as well (Gaby 2007).

Melatonin plays an important role in the brain, particularly in regulating the brain’s sleep-wake cycle. It also exerts a calming effect at the neuronal level by reducing glutaminergic (excitatory) signaling and augmenting GABAergic (inhibitory) signaling (Banach et al. 2011). Melatonin is widely used as a sleep aid and to treat jet lag; the side effects of taking melatonin are mild and it is one of the most commonly used supplements in the United States. Animal models have shown that melatonin can be effective in reducing epileptic seizures (Lima et al. 2011, Costa-Latufo et al. 2002). Melatonin has also been beneficial in humans with epilepsy and is particularly effective in the treatment of cases of juvenile epilepsy that do not respond well to anti-epileptic drugs (AED’s) (Banach et al. 2011). Due to its widespread use and minimal side effects, melatonin has potential to improve control of epilepsy (Fauteck et al. 1999).

Polyunsaturated Fatty Acids (PUFAs), such as omega-3 fatty acids, are a type of essential fat that play an important role in maintaining central nervous system health. Animal studies have suggested that PUFAs, including omega-3 and some omega-6 fatty acids, may be able to modulate neuronal excitability (Blondeau et al. 2002, Taha et al. 2010). This is further supported by the fact that children on the ketogenic diet often have higher levels of PUFAs in their cerebrospinal fluid, which suggests that increased PUFA levels is one of the ways that the ketogenic diet prevents seizures (Xu et al. 2008, Auvin 2011). Clinical trials in adults have yielded mixed results. In one such study, 57 epileptic patients were given 1 g EPA and 0.7 g DHA daily. Seizure activity was reduced over the first six weeks, although the effect was temporary. The researchers called for more in-depth studies, with larger doses and larger observational groups (Yuen AW et al 2005). However, a randomized controlled trial did not find that fish oil reduced seizure frequency; although, the study did find, that PUFAs reduced seizures when administered in an open-label format, meaning when subjects knew that they were not receiving a placebo (Bromfeld et al. 2008). An ongoing National Institutes of Health-sponsored trial is examining the effects of fish oil on cardiac health in epileptics (ClinicalTrials.gov).

Life Extension suggests that the omega-6 to omega-3 ratio should be kept below 4 to 1 for optimal health. More information on testing and optimizing your omega-6 to omega-3 ratio can be found in the Life Extension Magazine article entitled “Optimize Your Omega-3 Status“.

Resveratrol, derived from red grapes and Japanese knotweed (Polygonum cuspidatum), and the plant Bacopa monnieri both appear to be promising in the management of seizure-related neurotoxicity. Resveratrol and bacopa-derived compounds have been extensively studied in experimental settings and consistently shown to guard against neuronal damage (Jyoti 2007; Hosamani 2009; Kanthasamy 2011; Chung 2011). In the context of epilepsy, numerous mechanisms by which resveratrol might prevent seizures have been proposed (Shetty 2011), and, indeed, in an animal model resveratrol prevented chemical-induced seizures (Wu 2009); though studies on epileptic humans have yet to be performed. Likewise, bacopa has been the subject of several animal model experiments, many of which have revealed a clear benefit relating to seizure frequency and post-seizure brain cell damage (Pandey 2010; Mathew 2010; Krishnakumar 2009). Nonetheless, bacopa also has yet to be studied in a controlled manner in a population of epileptic humans.

Phytocannabinoids (pCBs), which are compounds found in marijuana that closely resemble chemicals the body produces naturally called endocannabinoids, have shown great potential in the treatment of epilepsy. Phytocannabinoids can affect both the central and peripheral nervous system because neurons have receptors that respond directly to binding by cannabinoids. One of the major effects of pCBs is to reduce neuronal excitability by modulating electrical activity around synapses; as a result, these chemicals are sometimes referred to as potential “circuit breakers” for neurological disorders, including epilepsy (Wallace et al. 2003, Katona and Freund 2008). Therefore, researchers have been studying the effects of tetrahydrocannabinol (THC) and other phytocannabinoids on the brain to try to develop new mechanisms for treating epilepsy (Hoffman and Frazier 2011, Hill et al 2012). One small clinical trial found that the phytocannabinoid, cannabidiol, did reduce seizures in epileptics who were already taking AEDs (Cunha et al 1980). Another study that was largely based on epidemiology found an association between marijuana use and decreased risk of seizure (Ng et al 1990). Moreover, it has been reported that patients treated for epilepsy subjectively feel that marijuana use helps eases their epilepsy (Gross et al 2004). More research is needed to determine the efficacy and safety of natural and synthetic cannabinoids for the treatment of seizures. A comprehensive review of studies examining the effects of cannabinoids on seizure frequency in humans is currently being carried out by the Cochrane Epilepsy Group (Gloss and Vickrey 2011). Marijuana is illegal except as a prescribed treatment for medical problems in certain states; Life Extension does not recommend consuming illegal drugs as a treatment for epilepsy. However, the benefits of these phytocannabinoids do suggest that marijuana-derived compounds may soon become an accepted form of therapy for epilepsy and other neurological disorders.

Lifestyle Modifications

Seizure Interruptions. Although auras do not occur in all individuals with seizure disorders, some people are aware of a change in their sensory perception (whether auditory, olfactory, sensory, visual, or gustatory, sometimes involving malaise, vertigo, or the sense of deja vu) that signals the onset of a seizure. Anecdotal reports indicate that some people have learned to interrupt their seizure process by replacing the aura-induced perception with another. In these individuals, the aura is a known signal of seizure onset. For example, if the aura is a smell or unpleasant odor, these individuals can often interrupt the seizure by immediately smelling something else (in general, something with a more pleasing smell than the aura).

Some people are able to take the interruption technique a step further. By simply relying on mental imagery (e.g., remembering a pleasant, positive smell), they can arrest a seizure. Some find that anger can effectively interrupt a seizure; they are able to arrest their seizures by yelling at them. Other individuals who have seizures with an observable onset pattern enlist a support person to shout at them or give them a quick shake when the pattern commences. The techniques that successfully “interrupt” an aura vary from patient to patient and must be performed at a specific time to stop the seizure (Wolf 1994). However, the use of aura interruption may be able to help reduce or eliminate seizures (Elsas et al. 2011).

Stress Reduction Getting a good night’s sleep on a regular basis is a very important component of seizure prevention. Some scientists hypothesize that one major function of REM sleep is to reduce the brain’s susceptibility to epileptogenic influences (Jaseja H 2004). Stress reduction and relaxation techniques such as meditation may also aid in reducing seizures (Swinehart 2008).

Physical exercise can also be an important way to relieve stress that may be particularly beneficial for epileptics. Not only can exercise reduce stress, improve social integration and improve quality of life, regular physical exercise may directly help reduce seizure frequency (Arida et al. 2010). Physical exercise may “desensitize” neurons to emotional stress, helping avert seizures brought on by other triggers (Arida et al. 2009).

Biofeedback, another relaxation technique, can also be helpful. When the autonomic nervous system (or the involuntary nervous system) is in a state of overarousal, the likelihood of seizure activity can increase. Biofeedback is a technique that uses displays of some form of biological monitoring, such as an EEG, to help patients identify how their body responds to certain situations. By observing changes in EEG readings, patients are able to learn how to partially control the electrical activity in their brains and can develop the ability to reduce their risk of having seizures. Although most clinical trials involving biofeedback have been small (Tozzo CA et al 1988; Andrews DJ et al 1992; Ramaratnam S et al 2001), a comprehensive review of many studies found that biofeedback can provide significant relief for epileptics, particularly those that have not had success with anti-epileptic drugs (AEDs) (Tan et al. 2009). On average, almost 75 percent of people who try EEG biofeedback for epilepsy will experience fewer seizures. Biofeedback using other biologic responses, such as slow cortical potential feedback and galvanic skin response has also been promising (Nagai 2011).

Other behavioral interventions may reduce seizure frequency as well. Yoga can improve quality of life and result in fewer seizures (Lundgren et al. 2008, Khan et al. 2010) Acupuncture may also be helpful in seizure prevention. A thorough review of published trials found that acupuncture may be beneficial, but that more and better designed studies need to be done (Cheuk 2008). Studies of the benefits of other relaxation techniques and cognitive behavioral therapy have also found a possible benefit (Ramaratnam 2004).


Disclaimer and Safety Information

This information (and any accompanying material) is not intended to replace the attention or advice of a physician or other qualified health care professional. Anyone who wishes to embark on any dietary, drug, exercise, or other lifestyle change intended to prevent or treat a specific disease or condition should first consult with and seek clearance from a physician or other qualified health care professional. Pregnant women in particular should seek the advice of a physician before using any protocol listed on this website. The protocols described on this website are for adults only, unless otherwise specified. Product labels may contain important safety information and the most recent product information provided by the product manufacturers should be carefully reviewed prior to use to verify the dose, administration, and contraindications. National, state, and local laws may vary regarding the use and application of many of the treatments discussed. The reader assumes the risk of any injuries. The authors and publishers, their affiliates and assigns are not liable for any injury and/or damage to persons arising from this protocol and expressly disclaim responsibility for any adverse effects resulting from the use of the information contained herein.

The protocols raise many issues that are subject to change as new data emerge. None of our suggested protocol regimens can guarantee health benefits. The publisher has not performed independent verification of the data contained herein, and expressly disclaim responsibility for any error in literature.

VITAMINS suggested by our Neurologist… | Epilepsy Foundation

 

 

I have now been using vitamin B6 to control my seizures for over 38 years. My seizure medication now consists of B vitamins only. In over 38 years I have never …

Keppra and vitamin B deficiency? | Epilepsy Foundation

 

 

Keppra and vitamin B deficiency? Topic: Medication Issues. Hi. I have been on Keppra for a few years, and experienced the not-so-uncommon increased anxiety …

Taking vitamins with seizure meds. what’re the risks? | Epilepsy …

 

 

The vitamins that seem most likely to make me feel worse post-seizure are Omega 3 and … Vitamin B6 – A necessary cofactor in the metabolism of a variety of …

Folic Acid, Vitamin B12 Supplements Can Benefit Epilepsy Patients on …

 

 

Oct 21, 2016 – Read about why folic acid and vitamin B12 supplements might reduce the risk of stroke in epilepsy patients on anti-seizure medication.

Vitamins, Minerals & Epilepsy Medication | thedaisygarland.org.uk

 

 

Calcium is a very important mineral for the normal functioning of brain cells, and low levels of calciumcan cause seizures. A deficiency of magnesium, a mineral …

Vitamin B(6) treatment of intractable seizures. – NCBI

 

 

by S Ohtahara – ‎2011 – ‎Cited by 17 – ‎Related articles

Brain Dev. 2011 Oct;33(9):783-9. doi: 10.1016/j.braindev.2011.01.010. Epub 2011 Feb 22. Vitamin B(6)treatment of intractable seizures. Ohtahara S(1) …

Clinical study on anti-epileptic drug with B vitamins for the treatment of …

 

by H Zhou – ‎2017 – ‎Cited by 2 – ‎Related articles

OBJECTIVE: To study the clinical value of anti-epileptic drugs combined with B vitamins in thetreatment of epilepsy after stroke. PATIENTS AND METHODS: The …

Vitamin Treatment for Seizures? – Dr. Weil

 

https://www.drweil.com › Health & Wellness › Balanced Living › Healthy Living

 

I have been told that vitamin B6 has been used to help patients with seizures. Is this true, and if so what dose do you recommend? – September 22, 2009.

 

 

Epileptics Living in High Crime Areas Have Three Times As Many Seizures

Epileptics Living in High Crime Areas Have Three Times As Many Seizures

Summary: According to a new study, those with epilepsy who live in high crime neighborhoods have three times as many seizures as those living in lower crime areas.

Source: University of Illinois.

People with epilepsy living in high crime neighborhoods in Chicago had three times as many seizures as those living in neighborhoods with lower crime rates according to new research from the University of Illinois at Chicago presented at the American Epilepsy Society 2018 conference in New Orleans.

Epilepsy is a chronic neurological disorder characterized by abnormal brain activity and seizures that affects more than 65 million people worldwide. About one-third have difficulty controlling their seizures even with medication. Seizures can interfere with work, relationships, and the ability to live independently. Previous research has shown that living in neighborhoods with high rates of crime have significantly higher levels of the stress hormone, cortisol. Stress is also a factor that is commonly reported to trigger seizures in people with epilepsy.

The UIC study included 63 adults with epilepsy living within the city limits of Chicago who were participating in a larger study testing the efficacy of a tablet-based educational tool that provides tailored information about epilepsy. That study, called PAUSE, involves patients at the University of Illinois Hospital’s epilepsy clinic and in the Chicagoland community and is facilitated by the Epilepsy Foundation of Greater Chicago.

The researchers determined the levels of crime in neighborhoods of the 63 participants by mapping their zip codes to specific neighborhoods and then cross-referencing those neighborhoods with local crime rates available through the City of Chicago Police data portal. Participants self-reported the number of seizures they had in the past month and in the past three months.

brain

“We found that people living with epilepsy who live in high-crime neighborhoods experienced significantly more seizures,” said Jessica Levy, a research coordinator in the UIC department of neurology and rehabilitation who presented the findings. “On average, people in high-crime neighborhoods had three seizures versus one for people living in low-crime neighborhoods when we looked back over the last 30 days. Over the course of 90 days, people in high-crime neighborhoods had seven seizures on average compared to three for those living in low-crime neighborhoods, so the link between crime and seizure activity is significant.”

The researchers found no overall association between neighborhood crime status and the duration of epilepsy or between crime status and poverty.

Having more seizures can significantly lower quality of life. Seizures that result in falls can cause bruising or even broken bones. There can also be a stigma associated with having a seizure in public.

“Understanding the impact of violence and crime as potential triggers for seizures underscores the need for further research that might allow clinicians to make better-informed recommendations for self-management education and stress management skills,” said Dr. Dilip Pandey, associate professor of neurology and rehabilitation at UIC and an investigator on the study.

ABOUT THIS NEUROSCIENCE RESEARCH ARTICLE

Katharine Ozenberger is a co-investigator on the study.

The PAUSE study is conducted through the UIC department of neurology and rehabilitation by Dr. Dilip Pandey and Dr. Jeffery Loeb.

Funding: PAUSE is supported by the University of Illinois Prevention Research Center and the Centers for Disease Control and Prevention (CDC) Managing Epilepsy Well (MEW) Network under CDC cooperative agreement no. U48-DP005010.

Source: Sharon Parmet – University of Illinois
Publisher: Organized by NeuroscienceNews.com.
Image Source: NeuroscienceNews.com image is in the public domain.
Original Research: The study will be presented at the American Epilepsy Society Meeting.

%d bloggers like this: